The independent UK regulator for fertility treatment and human embryo research, the Human Fertilisation and Embryology Authority (HFEA), has published its annual sector report covering the period from 1 April 2024 to 31 March 2025. The report provides an overview of inspections, incidents, clinic licensing, patient feedback and other regulatory activity in UK-licensed fertility clinics.

One of the headline findings is reassurance around safety: during the year over 100,000 fertility treatment, storage or donation cycles took place across licensed clinics, with incidents occurring in less than 1% of those cycles.  The total number of incidents reported rose by 36 %, from 581 in 2023/24 to 792 in 2024/25.  However, none of the incidents in 2024/25 were at the most serious “Grade A” level, and the majority of the increase was due to lower-grade (Grade C) incidents, many of which relate to clinic administration, laboratory process and minor clinical issues. 

In terms of regulatory oversight, the HFEA conducted 88 inspections in 2024/25 (down from 104 in the prior year), reflecting changes in licence term lengths introduced during the COVID-19 period.  During those inspections, 131 non-compliances were identified, down from 226 in the previous year (though also reflecting fewer inspections overall).  The number of licensed clinics rose to 141 in total, of which 107 were licensed to provide treatment (an increase of six clinics). 

The report also highlights evolving market dynamics. Private ownership remains dominant among treatment clinics: of the 107 treatment-licensed clinics, 71 (66 %) were privately owned and 49 of those were part of larger clinic groups.  Another noteworthy trend is that an increasing share of cycles are self-funded rather than funded via the UK National Health Service (NHS). The HFEA reports that only 27 % of cycles in recent periods were NHS-funded, compared with 35 % in 2019. 

Patient feedback remains broadly positive. Around 2,500 patients (about 5 % of patients treated or storing material in that period) submitted feedback via the HFEA’s “Choose a Fertility Clinic” web-platform. Of those, 84 % said they would be likely to recommend their clinic to friends or family, 95 % reported being treated with dignity and privacy, and 93 % said they understood what was happening during treatment. 

The HFEA signals particular concern around administrative incidents and communication failures. Many of the Grade C incidents (which increased notably by 53 %) involved administrative or laboratory process issues—examples include emails sent to the wrong recipient or treatment delay caused by scheduling or billing errors.  The regulator emphasises this as an area for improvement even in a broadly safe sector.

For labs, clinics and treatment-centres, the report offers a useful benchmarking tool. It suggests that while major safety failures remain extremely rare, there is ongoing need for attention to non-clinical aspects of service delivery—workflow, documentation, patient-communication and process consistency. Given the rise in self-funded patients and the diversification of treatment pathways (including virtual or app-based referral models), the regulatory landscape may become more complex. The HFEA notes that only licensed clinics can carry out certain treatment steps (such as embryo creation or storage) and warns patients may be confused about which services are regulated. 

In summary, the 2024/25 report from the HFEA shows a mature UK fertility treatment sector operating safely under regulatory oversight. Some operational and administrative challenge areas remain, but the data reinforce that major adverse events are rare and patient experience metrics are strong. For stakeholders in labs, clinics and research-partners, these findings provide context for quality assurance, process improvement and strategic planning.

Sources

13 November 2025. Human Fertilisation and Embryology Authority

• HFEA publishes the Fertility Sector 2024/25 report

13 November 2025. Human Fertilisation and Embryology Authority

• The fertility sector 2024/25: Annual publication on HFEA licensed clinics (1 April 2024 – 31 March 2025)